Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening
complication of allogeneic hematopoietic cell transplantation (HCT). We hypothesized that …

Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after
hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a multifactorial disorder
caused by systemic vascular endothelial injury that can be triggered by several mechanisms …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an infrequent but
devastating syndrome that occurs in allogeneic hematopoietic stem cell transplant …

There is increasing evidence that endothelial dysfunction is involved in refractoriness of
acute GvHD (aGvHD). Here we investigated the hypothesis that another endothelial …

Allogeneic hematopoietic cell transplantation (HCT) represents a vital procedure for patients
with various hematologic conditions. Despite advances in the field, HCT carries significant …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a fatal complication after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous reports suggest …

Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of
allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA …

Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is an understudied complication of HSCT that significantly affects transplant-related …